Results 311 to 320 of about 63,359 (335)

Genomic landscape of biliary tract cancer and corresponding targeted treatment strategies. [PDF]

Int J Clin Oncol
Yamada D, Kobayashi S, Doki Y, Eguchi H.
europepmc   +1 more source

Oncogenic IDH1^mut drives robust loss of histone acetylation and increases chromatin heterogeneity. [PDF]

Proc Natl Acad Sci U S A
Furth N, Cohen N, Spitzer A, Salame TM, Dassa B, Mehlman T, Brandis A, Moussaieff A, Friedmann-Morvinski D, Castro MG, Fortin J, Suvà ML, Tirosh I, Erez A, Ron G, Shema E.   +15 more
europepmc   +1 more source

Therapy enhancing chromosome instability may be advantageous for <i>IDH1</i> ^R132H/WT gliomas. [PDF]

NAR Cancer
Goncharov NV, Baklanov IN, Gulaia VS, Shuliak AP, Lanskikh DV, Zhmenia VM, Shmelev ME, Shved NA, Wu J, Liskovykh M, Larionov V, Kouprina N, Kumeiko VV.   +12 more
europepmc   +1 more source

Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors. [PDF]

Neuro Oncol
Ghosh HS, Patel RV, Woodward E, Greenwald NF, Bhave VM, Maury EA, Cello G, Hoffman SE, Li Y, Gupta H, Youssef G, Spurr LF, Vogelzang J, Touat M, Dubois F, Cherniack AD, Guo X, Tavakol S, Cioffi G, Lindeman NI, Ligon AH, Chiocca EA, Reardon DA, Wen PY, Meredith DM, Santagata S, Barnholtz-Sloan JS, Ligon KL, Beroukhim R, Bi WL.   +29 more
europepmc   +1 more source

Astrocytomas IDH-mutant of posterior cranial fossa, clinical presentation, imaging features and onco-functional balance in surgical management. [PDF]

Neurosurg Rev
De Simone M, Choucha A, Ranalli C, Pecoraro G, Appay R, Chinot OL, Dufour H, Iaconetta G.   +7 more
europepmc   +1 more source

Protein Phosphatase 1 Regulatory Subunit 3C integrates cholesterol metabolism and isocitrate dehydrogenase in chondrocytes and neoplasia. [PDF]

Proc Natl Acad Sci U S A
Nakagawa M, Shimada E, Guardino N, Miyamoto R, Puviindran V, Peairs E, Matarangas A, Ishikawa K, Nguyen T, Browne M, Marius C, Wallace A, Hirata M, Nadesan P, Alman BA.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Multichannel Sonocatalysis Amplifiers Target IDH1‐Mutated Tumor Plasticity and Attenuate Ros Tolerance to Repress Malignant Cholangiocarcinoma

Advanced Functional Materials, 2023
Tumor adaptation‐originated tumor tolerance that compensatory mechanisms (e.g., isocitrate dehydrogenase (IDH) mutation) jointly shape is the dominant obstacle of ROS therapy.
Duo Wang, Xiaoqi Zhu, Xiaobo Wang, Qin Wang, Kangning Yan, Guichun Zeng, Guanhua Qiu, Rong Jiao, Xia Lin, Jie Chen, Qiaoling Yang, Wen Qin, Jun Liu, Kun Zhang, Yan Liu   +14 more
semanticscholar   +1 more source